The Association for the Cannabinoid Industry is a membership organisation committed to nurturing a safe, legal and well regulated CBD market in the UK.

Become a member

Find out more about The ACI
See our Membership Prospectus 2020-2021


Understand how to keep products on the shelves after FSA’s 31 March 2021 deadline.


Identify compliant ingredient suppliers to open opportunities to work with more CBD brands.


Understand which brands and products to stock and why.

Become a member

The ACI is committed to the development of a legal, safe and regulated CBD market. A fundamental aspect of achieving this is ensuring that consumers have confidence in our products.

The key benchmarks for this are how many people express confidence in the efficacy of our products, and how many would be more likely to do so if there was better regulation.

In that context, the findings from our YouGov survey* are truly illuminating: they are a vindication of why we set up the ACI, launched the ACI charter and committed our members to working towards full novel foods authorisation and standardisation of analytical testing methodologies.

* Methodology: This survey has been conducted using an online interview administered to members of the YouGov Plc UK panel of 800,000+ individuals who have agreed to take part in surveys. Read More

7 Jul, 2020

The ACI to Partner with VOXPO for B2C and B2B CBD Event

The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.

19 Jun, 2020

The ACI Responds to Global Regulatory Calls for Evidence of CBD Safety by Launching Study Consortium

The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.

17 Jun, 2020

ACI Bolsters Regulatory and Compliance Unit To Support UK CBD Industry

The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.

3 Aug, 2020

[New Food] The Potential Impact of Classifying CBD as a Narcotic

The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.

27 Jul, 2020

[Food Navigator] Love Hemp: ‘We’ve positioned ourselves as a global brand’

The CBD industry has just been dealt a potentially dangerous blow, however, with the news that the European Commission is considering classifying it as a narcotic instead of a Novel Food. While a decision won’t be made before September, it could mean that hundreds of CBD and hemp products would be unable to legally retail on the European market.

20 Jul, 2020

[BusinessCann] Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

Confirmation that the European Union is looking to treat CBD as a narcotic drug have rocked the industry.

BusinessCann reported earlier this month that moves were underway to change the status of cannabidiol (CBD) in the European Union from a food to a drug.

Become a Member

Membership enquiries 0800 310 10 54

Lines open from 10am-6pm. By calling this number you agree to the terms of our privacy policy.

To find out more about membership, fill in the form below and our team will get back to you soon.

I require help with novel foods application